Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Cash & Equivalents (2016 - 2025)

Alkermes (ALKS) has disclosed Cash & Equivalents for 16 consecutive years, with $388.6 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 33.46% to $388.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $388.6 million through Dec 2025, up 33.46% year-over-year, with the annual reading at $388.6 million for FY2025, 33.46% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $388.6 million at Alkermes, down from $616.4 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $665.8 million in Q2 2023, with the low at $205.0 million in Q1 2021.
  • Average Cash & Equivalents over 5 years is $393.3 million, with a median of $363.1 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents soared 161.46% in 2023, then plummeted 38.82% in 2024.
  • Over 5 years, Cash & Equivalents stood at $337.5 million in 2021, then fell by 13.35% to $292.5 million in 2022, then soared by 56.41% to $457.5 million in 2023, then tumbled by 36.36% to $291.1 million in 2024, then surged by 33.46% to $388.6 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $388.6 million, $616.4 million, and $521.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.